Literature DB >> 2718372

Detection of IgE antibodies to bovine respiratory syncytial virus.

R S Stewart1, L J Gershwin.   

Abstract

The role of IgE antibodies against respiratory syncytial virus has attracted attention for both human and bovine disease. To detect such antibodies, we have developed an enzyme-linked immunosorbent assay (ELISA) specific for bovine respiratory syncytial virus (BRSV). Firstly, antiserum strongly positive for BRSV-specific IgE was produced by immunizing a levamisole-treated calf with BRSV. The presence and specificity of BRSV-specific IgE in this animal was confirmed with the Praunitz-Kustner (PK) technique. Potential interference in an ELISA by other BRSV-specific immunoglobulin isotypes was eliminated by preferential precipitation of serum samples with 27.5% saturated ammonium sulfate. The correlation between the PK and the assay was greater than 93% and the ELISA was found to be more specific than the PK. Indeed, in a pilot experimental infection study, the serum levels of BRSV-specific IgE were found to correlate with the symptom expression following repetitive live virus aerosolization. This may prove to be a useful rapid test to study both herd immunity and the potential pathogenic influence of IgE.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2718372     DOI: 10.1016/0165-2427(89)90077-9

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  8 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 2.  Animal models of respiratory syncytial virus infection and disease.

Authors:  Randy E Sacco; Russell K Durbin; Joan E Durbin
Journal:  Curr Opin Virol       Date:  2015-07-11       Impact factor: 7.090

3.  Undetectable IgE responses after respiratory syncytial virus infection.

Authors:  G L Toms; R Quinn; J W Robinson
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

Review 4.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

5.  A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.

Authors:  Fabián E Díaz; Mariana Guerra-Maupome; Paiton O McDonald; Daniela Rivera-Pérez; Alexis M Kalergis; Jodi L McGill
Journal:  Front Immunol       Date:  2021-04-26       Impact factor: 7.561

Review 6.  Mechanistic bases for adverse vaccine reactions and vaccine failures.

Authors:  J A Roth
Journal:  Adv Vet Med       Date:  1999

7.  A randomized controlled trial comparing non-steroidal anti-inflammatory and fusion protein inhibitors singly and in combination on the histopathology of bovine respiratory syncytial virus infection.

Authors:  Francisco R Carvallo Chaigneau; Paul Walsh; Maxim Lebedev; Victoria Mutua; Heather McEligot; Heejung Bang; Laurel J Gershwin
Journal:  PLoS One       Date:  2021-06-10       Impact factor: 3.240

Review 8.  Neonatal calf infection with respiratory syncytial virus: drawing parallels to the disease in human infants.

Authors:  Randy E Sacco; Jodi L McGill; Mitchell V Palmer; John D Lippolis; Timothy A Reinhardt; Brian J Nonnecke
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.